Dr. Lal Path Labs Ltd. Total Assets
Dr. Lal Path Labs Ltd. total assets. Based on the latest financial reports, Dr. Lal Path Labs Ltd. (LALPATHLAB) holds total assets worth Rs31.46 Billion INR (≈ $340.23 Million USD) as of March 2026. Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments. Also see LALPATHLAB company net worth for the company's overall valuation and market capitalisation.
Total Assets of Dr. Lal Path Labs Ltd. (2011–2026)
Total assets of Dr. Lal Path Labs Ltd. from 2011 to 2026. This chart illustrates how Dr. Lal Path Labs Ltd.'s total assets have evolved over time, based on quarterly financial data. See LALPATHLAB live share price for real-time trading data and today's change.
Dr. Lal Path Labs Ltd. - Asset Composition Analysis
Dr. Lal Path Labs Ltd. Total Assets Breakdown (March 2026)
Dr. Lal Path Labs Ltd. total assets breakdown as of March 2026. Dr. Lal Path Labs Ltd.'s total assets of Rs31.46 Billion consist of 49.8% current assets and 50.2% non-current assets.
| Asset Category | Amount (INR) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | Rs0.00 | 28.9% |
| Accounts Receivable | Rs1.12 Billion | 3.6% |
| Inventory | Rs439.00 Million | 1.4% |
| Property, Plant & Equipment | Rs0.00 | 0.0% |
| Intangible Assets | Rs1.93 Billion | 6.1% |
| Goodwill | Rs5.48 Billion | 17.4% |
Asset Composition Trend (2011–2026)
This chart illustrates how Dr. Lal Path Labs Ltd.'s asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution. Explore LALPATHLAB working capital efficiency to assess how much short-term liquidity the company maintains relative to its equity base.
Key Asset Composition Facts
- Current vs. Non-Current Assets: Dr. Lal Path Labs Ltd.'s current assets represent 49.8% of total assets in 2026, an increase from 25.9% in 2011.
- Cash Position: Cash and equivalents constituted 28.9% of total assets in 2026, up from 2.6% in 2011.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 23.0% of total assets, a decrease from 24.0% in 2011.
- Asset Diversification: The largest asset category is goodwill at 17.4% of total assets.
Dr. Lal Path Labs Ltd. Competitors by Total Assets
Key competitors of Dr. Lal Path Labs Ltd. based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
Revvity Inc.
NYSE:RVTY
|
USA | $12.00 Billion |
|
Diagnósticos da América S.A
SA:DASA3
|
Brazil | R$21.10 Billion |
|
SMO ClinPlus Co. Ltd.
SHE:301257
|
China | CN¥1.52 Billion |
|
Monash Ivf Group Ltd
AU:MVF
|
Australia | AU$512.35 Million |
|
RHYTHM Biosciences Ltd
AU:RHY
|
Australia | AU$3.10 Million |
|
Bcal Diagnostics Ltd
AU:BDX
|
Australia | AU$7.66 Million |
|
Sonic Healthcare Ltd
AU:SHL
|
Australia | AU$16.78 Billion |
|
Integral Diagnostics Ltd
AU:IDX
|
Australia | AU$1.43 Billion |
Dr. Lal Path Labs Ltd. - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 3.48 | 3.39 | 4.18 |
| Quick Ratio | 3.38 | 3.30 | 4.02 |
| Cash Ratio | 0.00 | 2.08 | 0.00 |
| Working Capital | Rs11.16 Billion | Rs9.61 Billion | Rs8.71 Billion |
Dr. Lal Path Labs Ltd. - Advanced Valuation Insights
This section examines the relationship between Dr. Lal Path Labs Ltd.'s asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 11.54 |
| Latest Market Cap to Assets Ratio | 0.12 |
| Asset Growth Rate (YoY) | 15.8% |
| Total Assets | Rs31.46 Billion |
| Market Capitalization | $3.66 Billion USD |
Valuation Analysis
Below Book Valuation: The market values Dr. Lal Path Labs Ltd.'s assets below their book value (0.12x), which may indicate investor concerns about asset quality or future growth.
Rapid Asset Growth: Dr. Lal Path Labs Ltd.'s assets grew by 15.8% over the past year, indicating significant expansion of the company's resource base.
Annual Total Assets for Dr. Lal Path Labs Ltd. (2011–2026)
The table below shows the annual total assets of Dr. Lal Path Labs Ltd. from 2011 to 2026.
| Year | Total Assets | Change |
|---|---|---|
| 2026-03-31 | Rs31.46 Billion ≈ $340.23 Million |
+15.80% |
| 2025-03-31 | Rs27.17 Billion ≈ $293.81 Million |
+10.62% |
| 2024-03-31 | Rs24.56 Billion ≈ $265.60 Million |
+2.95% |
| 2023-03-31 | Rs23.86 Billion ≈ $257.98 Million |
+1.37% |
| 2022-03-31 | Rs23.53 Billion ≈ $254.49 Million |
+41.65% |
| 2021-03-31 | Rs16.61 Billion ≈ $179.67 Million |
+20.89% |
| 2020-03-31 | Rs13.74 Billion ≈ $148.63 Million |
+26.03% |
| 2019-03-31 | Rs10.90 Billion ≈ $117.93 Million |
+18.68% |
| 2018-03-31 | Rs9.19 Billion ≈ $99.37 Million |
+20.25% |
| 2017-03-31 | Rs7.64 Billion ≈ $82.64 Million |
+22.22% |
| 2016-03-31 | Rs6.25 Billion ≈ $67.62 Million |
+31.54% |
| 2015-03-31 | Rs4.75 Billion ≈ $51.40 Million |
+35.22% |
| 2014-03-31 | Rs3.52 Billion ≈ $38.02 Million |
+30.67% |
| 2013-03-31 | Rs2.69 Billion ≈ $29.09 Million |
+51.95% |
| 2012-03-31 | Rs1.77 Billion ≈ $19.15 Million |
+4.36% |
| 2011-03-31 | Rs1.70 Billion ≈ $18.35 Million |
-- |
About Dr. Lal Path Labs Ltd.
Dr. Lal PathLabs Limited operates laboratories for carrying out pathological investigations in India and internationally. The company provides pathological investigations of various branches of bio-chemistry, hematology, histopathology, microbiology, electrophoresis, immuno-chemistry, immunology, virology, cytology, and other pathological and radiological investigations. It also offers phlebotomi… Read more